keep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JSH-150 是一种高选择性的 CDK9抑制剂, IC50为 1 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 285 | 现货 | ||
5 mg | ¥ 892 | 现货 | ||
10 mg | ¥ 1,570 | 现货 | ||
25 mg | ¥ 2,890 | 现货 | ||
50 mg | ¥ 3,730 | 现货 | ||
100 mg | ¥ 5,380 | 现货 | ||
500 mg | ¥ 11,200 | 现货 |
产品描述 | JSH-150 is a highly selective CDK9 inhibitor(IC50 : 1 nM). |
靶点活性 | CDK14-CyclinY:1.68 μM, CDK2-CyclinA:2.86 μM, CDK5-p25:4.64 μM, CDK16-CyclinY:292 nM, CDK7-CyclinH-MNAT1:1.72 μM, CDK9-CyclinT1:1 nM, CDK1-CyclinB:1.34 μM |
体外活性 | A highly selective inhibitor compound 40 (JSH-150), which exhibited an IC50 of 1 nM against CDK9 kinase in the biochemical assay and achieved around 300 10000-fold selectivity over other CDK kinase family members.?In addition, it also displayed high selectivity over other 468 kinases/mutants (KINOMEscan S score(1) = 0.01).Compound 40 displayed potent antiproliferative effects against melanoma, neuroblastoma, hepatoma, colon cancer, lung cancer as well as leukemia cell lines.?It could dose-dependently inhibit the phosphorylation of RNA Pol II, suppress the expression of MCL-1 and c-Myc, arrest the cell cycle and induce the apoptosis in the leukemia cells. |
体内活性 | In the MV4-11 cell-inoculated xenograft mouse model, 10 mg/kg dosage of 40 could almost completely suppress the tumor progression.?The high selectivity and good in vivo PK/PD profile suggested that 40 would be a good pharmacological tool to study CDK9-mediated physiology and pathology as well as a potential drug candidate for leukemia and other cancers. |
分子量 | 505.08 |
分子式 | C24H33ClN6O2S |
CAS No. | 2247481-21-4 |
keep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 16 mg/mL (31.68 mM), Sonification is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.9799 mL | 9.8994 mL | 19.7988 mL | 49.4971 mL |
5 mM | 0.396 mL | 1.9799 mL | 3.9598 mL | 9.8994 mL | |
10 mM | 0.198 mL | 0.9899 mL | 1.9799 mL | 4.9497 mL | |
20 mM | 0.099 mL | 0.495 mL | 0.9899 mL | 2.4749 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
JSH-150 2247481-21-4 Cell Cycle/Checkpoint CDK inhibit Cyclin dependent kinase Inhibitor JSH 150 JSH150 inhibitor